Announcements Trials
Browse Landscape

Phase

Phase 1 144Phase NA 62Phase 2 55Phase 1/2 39Phase EARLY_PHASE1 6Phase 3 6Phase 4 3Phase 2/3 3

Status

Completed 33Unknown 20Withdrawn 5Recruiting 5Terminated 3Active not recruiting 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 29Genitourinary 23Thoracic 20Breast 19Other hematologic neoplasm 16Lymphoid 14Dermatologic 10Gynecologic 8Classical hematology 8Head & Neck 6Myeloid 5CNS 4Tumor-Agnostic 3Sarcoma 3Other 3Plasma cell 2Endocrine 2Other solid neoplasm 1Other neoplasm 1NET 1

Conditions

Neoplasms 2Neoplasm Metastasis 1

Interventions

pentetreotide 1Indium-111 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Terminated × Tumor-Agnostic × Clear all
NCT00944372 2016-09-09

Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors

Mallinckrodt

Phase 4 Terminated
150 enrolled
Tumor-Agnostic

Neoplasms

NCT02213653 2015-04-29

Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency

Centre Francois Baclesse

Phase 4 Terminated
24 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT00358111 2014-05-13

Study of LUMA Cervical Imaging System as Adjunct to Colposcopy

SpectraScience

Phase 4 Terminated
10 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡